Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Ericzon BG |
Early graft function in liver transplantation patients. |
1994 |
Transplant. Proc. |
pmid:7527965
|
Shaeffer MS et al. |
Interaction between FK506 and erythromycin. |
1994 |
Ann Pharmacother |
pmid:7513563
|
Ricordi C et al. |
Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. |
1994 |
Transplant. Proc. |
pmid:7527967
|
Lhöest GJ et al. |
15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity. |
1994 |
Clin. Chem. |
pmid:7513627
|
Ueda H et al. |
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. |
1994 |
J. Antibiot. |
pmid:7513682
|
Tai J et al. |
Effect of FK506 on rat Leydig cell function--in vivo and in vitro study. |
1994 |
Metab. Clin. Exp. |
pmid:7513780
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Atcherson MM and Trifillis AL |
Cytotoxic effects of FK506 on human renal proximal tubule cells in culture. |
1994 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:7529625
|
Maruyama K et al. |
FK 506 for vascular permeability factor production in minimal change nephrotic syndrome. |
1994 |
Nephron |
pmid:7517020
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Peattie DA et al. |
Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12. |
1994 |
Gene |
pmid:7529739
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Dawson VL et al. |
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. |
1994 |
Neuropharmacology |
pmid:7532825
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Okamoto M et al. |
Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7518145
|
Ippoliti G et al. |
Serum cytokine levels after small bowel transplantation in pigs. |
1994 |
Transplant. Proc. |
pmid:7518146
|
Orita T et al. |
Effect of FK 506 in combination with prednisolone on the graft-vs-host reaction after small bowel transplantation in rats. |
1994 |
Transplant. Proc. |
pmid:7518147
|
Porayko MK et al. |
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. |
1994 |
Mayo Clin. Proc. |
pmid:7508536
|
Kao PN et al. |
Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. |
1994 |
J. Biol. Chem. |
pmid:7519613
|
Martin MF |
Nephrotoxic effects of immunosuppression. |
1994 |
Mayo Clin. Proc. |
pmid:7508537
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Connelly PR et al. |
Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7510408
|
Shiraga T et al. |
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. |
1994 |
Biochem. Pharmacol. |
pmid:7510480
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Bell A et al. |
Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. |
1994 |
Biochem. Pharmacol. |
pmid:7520696
|
Paslaru L et al. |
GRP78 induction by cyclosporin A in human HeLa cells. |
1994 |
FEBS Lett. |
pmid:7520875
|
Gailliot FP et al. |
Isolation and characterization of the major equilibrium product of FK-520. |
1994 |
J. Antibiot. |
pmid:7520900
|
Sharkey J and Butcher SP |
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. |
1994 |
Nature |
pmid:7522303
|
Bram RJ and Crabtree GR |
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. |
1994 |
Nature |
pmid:7522304
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Ueda K et al. |
Human P-glycoprotein as a multi-drug transporter analyzed by using transepithelial transport system. |
1994 |
Jpn. J. Physiol. |
pmid:7538609
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Heitman J et al. |
Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition. |
1994 |
Transplant. Proc. |
pmid:7524220
|
Yoshimura R et al. |
Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat. |
1994 |
Transplant. Proc. |
pmid:7524223
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Bush KT et al. |
Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. |
1994 |
Biochem. J. |
pmid:7526846
|
Kahan BD |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. |
1994 |
Ther Immunol |
pmid:7584478
|
Akamine S et al. |
Monitoring canine lung allograft rejection using Ia antigen expression by bronchoalveolar lymphocytes. |
1994 |
Surg. Today |
pmid:7526914
|
Tsuchida M et al. |
The effects of FK506 and dexamethasone on rat thymocyte differentiation. |
1994 |
Ther Immunol |
pmid:7584489
|
Lemoine A et al. |
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantation. |
1994 |
Hepatology |
pmid:7527003
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|
Mor E et al. |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. |
1994 |
Transpl. Int. |
pmid:11271340
|
Uemoto S et al. |
Long-term use of FK 506 in living related liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271341
|
Dmitrewski J et al. |
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? |
1994 |
Transpl. Int. |
pmid:11271342
|
Lhoëst G et al. |
Isolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes. |
1993 Sep-Oct |
Drug Metab. Dispos. |
pmid:7694828
|
Iwasaki K et al. |
Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone. |
1993 Nov-Dec |
Drug Metab. Dispos. |
pmid:7507815
|
Fukuse T et al. |
Combined therapy with FK-506 and cyclosporine for canine lung allotransplantation: immunosuppressive effects and blood trough levels. |
1993 Nov-Dec |
J. Heart Lung Transplant. |
pmid:7508750
|
Morris RE |
New small molecule immunosuppressants for transplantation: review of essential concepts. |
1993 Nov-Dec |
J. Heart Lung Transplant. |
pmid:7508752
|
Schreier MH |
Immunophilins and immunosuppression. |
1993 Mar-Apr |
Clin. Exp. Rheumatol. |
pmid:7686830
|
Piekoszewski W et al. |
Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. |
1993 Jul-Aug |
Drug Metab. Dispos. |
pmid:7690698
|
Kobayashi J et al. |
A new rat infection-heart transplant model: effect of infection on graft survival studies. |
1993 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7690253
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Azhderian EM et al. |
Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679834
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Nelson PA et al. |
Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. |
1993 |
J. Immunol. |
pmid:7680683
|
Piekoszewski W and Jusko WJ |
Plasma protein binding of tacrolimus in humans. |
1993 |
J Pharm Sci |
pmid:7680714
|
Ning YM and Sánchez ER |
Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. |
1993 |
J. Biol. Chem. |
pmid:7681058
|
Saeki T et al. |
Human P-glycoprotein transports cyclosporin A and FK506. |
1993 |
J. Biol. Chem. |
pmid:7681059
|
Fabrega AJ et al. |
Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. |
1993 |
Transplantation |
pmid:7506458
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Winkler ME et al. |
Successful pregnancy in a patient after liver transplantation maintained on FK 506. |
1993 |
Transplantation |
pmid:7506460
|
Yoshizawa K et al. |
Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient. |
1993 |
Cancer Genet. Cytogenet. |
pmid:7506636
|
Distant DA and Gonwa TA |
The kidney in liver transplantation. |
1993 |
J. Am. Soc. Nephrol. |
pmid:7691205
|
Muthukkumar S et al. |
Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma. |
1993 |
Eur. J. Immunol. |
pmid:7691606
|
Wesselborg S et al. |
Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. |
1993 |
Eur. J. Immunol. |
pmid:7691614
|
Schulz BS et al. |
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. |
1993 |
J. Immunol. |
pmid:7691948
|
Travis J |
Making molecular matches in the cell. |
1993 |
Science |
pmid:7694368
|
Jusko WJ and Kobayashi M |
Therapeutic monitoring of tacrolimus (FK 506) |
1993 |
Ther Drug Monit |
pmid:7694395
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Akamine S et al. |
[Effect of FK-506 on bronchial healing of canine lung allografts]. |
1993 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7685803
|
Partaledis JA and Berlin V |
The FKB2 gene of Saccharomyces cerevisiae, encoding the immunosuppressant-binding protein FKBP-13, is regulated in response to accumulation of unfolded proteins in the endoplasmic reticulum. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7685904
|
Sykes K et al. |
Proline isomerases function during heat shock. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7685914
|
Suzuki S et al. |
Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7685932
|
Abu-Elmagd K et al. |
Recent advances in hepatic transplantation at the University of Pittsburgh. |
1993 |
Clin Transpl |
pmid:7522528
|
Ueki M et al. |
Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. |
1993 |
Diabetes Res. Clin. Pract. |
pmid:7688276
|
Pleyer U et al. |
Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7688360
|
Machida M |
[Effect of temperature on plasma concentration of FK506]. |
1993 |
Nippon Hinyokika Gakkai Zasshi |
pmid:7688443
|
Schmid FX |
Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. |
1993 |
Annu Rev Biophys Biomol Struct |
pmid:7688608
|
Kino T and Goto T |
Discovery of FK-506 and update. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689804
|
Parsons WH et al. |
FK-506--a novel immunosuppressant. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689805
|
Zenke G et al. |
Molecular mechanisms of immunosuppression by cyclosporins. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689806
|
Clardy J |
Structural studies of complexed FK-506 binding protein. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689808
|
Meadows RP et al. |
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. |
1993 |
Biochemistry |
pmid:7678499
|
Jiang H et al. |
Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. |
1993 |
Carcinogenesis |
pmid:7678785
|
Naito M et al. |
Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. |
1993 |
J. Natl. Cancer Inst. |
pmid:7678867
|
Barthelmess IB and Tropschug M |
FK506-binding protein of Neurospora crassa (NcFKBP) mediates sensitivity to the immunosuppressant FK506; resistant mutants identify two loci. |
1993 |
Curr. Genet. |
pmid:7679056
|